Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Bridging the gap between scientific discoveries and clinical application at the Utrecht Science Park
Peperzak, V. & Coquet, J. M., Apr 2024, In: Immunology and Cell Biology. 102, 4, p. 232-234 3 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Identifying clinical response to daratumumab therapy in relapsed/refractory multiple myeloma using a patient-derived in vitro model
van Nieuwenhuijzen, N., Cuenca, M., Abbink, L., Jak, M., Peperzak, V. & Minnema, M. C., Feb 2024, In: EJHaem. 5, 1, p. 141-146 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma
Greve, P., Beishuizen, A., Hagleitner, M., Loeffen, J., Veening, M., Boes, M., Peperzak, V., Diez, C. & Meyer-Wentrup, F., 2023, In: Frontiers in Immunology. 14, 1229558.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile12 Downloads (Pure) -
Serpin B9 controls tumor cell killing by CAR T cells
Kimman, T., Slomp, A., Martens, A., Grabherr, S., Li, S., van Diest, E., Meeldijk, J., Kuball, J., Minnema, M. C., Eldering, E., Bovenschen, N., Sebestyén, Z. & Peperzak, V., 17 Mar 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3, e006364.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Downloads (Pure) -
Wnt inhibitors reduce the unfolded protein response and enhance bortezomib-induced cell death in multiple myeloma
Spaan, I., van Nieuwenhuijzen, N., Kimman, T., Rockx-Brouwer, D., Tieland, R. G., Maurice, M., Minnema, M. C., Raymakers, R. & Peperzak, V., 11 Apr 2023, In: Blood Advances. 7, 7, p. 1103-1107 5 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile19 Downloads (Pure)
Prizes
-
Dutch Cancer Society/KWF personal Bas Mulder Award: Towards therapeutic targeting of Myeloid cell leukemia 1 (MCL-1) in B cell cancers.
Peperzak, Victor (Recipient), 2015
Prize: Fellowship awarded competitively
-
Dutch Cancer Society/KWF Research Project: Personalized strategy to avert drug resistance in hematologic cancers.
Peperzak, Victor (Recipient), Minnema, Monique (Recipient) & Jak, Margot (Recipient), 2017
Prize: Fellowship awarded competitively
-
Dutch Cancer Society/KWF Unique High Risk Project: Empowering the T cell killing machinery to eradicate cancer cells and prevent outgrowth.
Peperzak, Victor (Recipient) & Sebestyen, Szolt (Recipient), 2018
Prize: Fellowship awarded competitively
-
-
KWF/Alpe d'HuZes Research Project grant: Optimized Killing (OK) technology to empower engineered T or NK cells in the treatment of cancer.
Peperzak, Victor (Recipient) & Sebestyen, Szolt (Recipient), 2020
Prize: Fellowship awarded competitively